[18F] POSITRON EMISSION COMPUTED TOMOGRAPHY ([18F] FDG PET/CT) IS ABLE TO DEFINED REMISSION IN RHEUMATOID ARTHRITIS

被引:0
|
作者
Rinkin, C. [1 ]
Florane, C. [1 ]
Gerard, C. [1 ]
Seidel, L. [1 ]
Lamaye, C. [2 ]
Hustinx, R. [2 ]
Malaise, M. [1 ]
Ribbens, C. [1 ]
Malaise, O. [1 ]
机构
[1] Univ Hosp Liege, Rheumatol Dept, Liege, Belgium
[2] Univ Hosp Liege, Nucl Med Dept, Liege, Belgium
关键词
Inflammatory arthritides;
D O I
10.1136/annrheumdis-2023-eular.2190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0919
引用
收藏
页码:770 / 770
页数:1
相关论文
共 50 条
  • [11] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (10): : 511 - 522
  • [12] Dual-Tracer Positron Emission Tomography/Computed Tomography with [18F]FDG and [18F]fluorocholine in a Patient with Metastatic Parathyroid Carcinoma
    Iacovitti, Cesare Michele
    Cuzzocrea, Marco
    Gianola, Lauro
    Paone, Gaetano
    Treglia, Giorgio
    DIAGNOSTICS, 2024, 14 (14)
  • [13] Robustness of radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Vuong, D.
    Bogowicz, M.
    Huellner, M.
    Veit-Haibach, P.
    Andratschke, N.
    Unkelbach, J.
    Guckenberger, M.
    Tanadini-Lang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S41 - S41
  • [14] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Alexis Vrachimis
    Matthias Christian Burg
    Christian Wenning
    Thomas Allkemper
    Matthias Weckesser
    Michael Schäfers
    Lars Stegger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 212 - 220
  • [15] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Vrachimis, Alexis
    Burg, Matthias Christian
    Wenning, Christian
    Allkemper, Thomas
    Weckesser, Matthias
    Schaefers, Michael
    Stegger, Lars
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 212 - 220
  • [16] Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Diem Vuong
    Tanadini-Lang, Stephanie
    Huellner, Martin W.
    Veit-Haibach, Patrick
    Unkelbach, Jan
    Andratschke, Nicolaus
    Kraft, Johannes
    Guckenberger, Matthias
    Bogowicz, Marta
    MEDICAL PHYSICS, 2019, 46 (04) : 1677 - 1685
  • [17] The use of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) for predicting recurrence in cervical cancer patients
    Brunette, L.
    Mehta, A.
    Lieber, D.
    Bonyadlou, S.
    Lin, Y.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 389 - 389
  • [18] Robustness study on radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Vuong, D.
    Bogowicz, M.
    Huellner, M.
    Veit-Haibach, P.
    Andratschke, N.
    Unkelbach, J.
    Guckenberger, M.
    Tanadini-Lang, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1159 - S1159
  • [19] The best way for glycaemia measurement in patients undergoing 18F Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)
    Trevisan, M.
    Carpin, E.
    Biscotto, A.
    Zonzin, G.
    Saladini, G.
    Evangelista, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S513 - S513
  • [20] [18F]Difluorocarbene for positron emission tomography
    Sap, Jeroen B. I.
    Meyer, Claudio F.
    Ford, Joseph
    Straathof, Natan J. W.
    Durr, Alexander B.
    Lelos, Mariah J.
    Paisey, Stephen J.
    Mollner, Tim A.
    Hell, Sandrine M.
    Trabanco, Andres A.
    Genicot, Christophe
    Am Ende, Christopher W.
    Paton, Robert S.
    Tredwell, Matthew
    Gouverneur, Veronique
    NATURE, 2022, 606 (7912) : 102 - +